Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.476M
March 31, 2026 1.521M
December 31, 2025 3.502M
September 30, 2025 2.212M
June 30, 2025 -0.266M
March 31, 2025 0.574M
December 31, 2024 -4.692M
September 30, 2024 1.456M
June 30, 2024 0.913M
March 31, 2024 3.96M
December 31, 2023 0.077M
September 30, 2023 0.266M
June 30, 2023 0.475M
March 31, 2023 2.203M
December 31, 2022 -0.904M
September 30, 2022 2.714M
June 30, 2022 -5.648M
March 31, 2022 0.007M
December 31, 2021 1.282M
September 30, 2021 1.841M
June 30, 2021 -0.198M
March 31, 2021 -4.453M
December 31, 2020 -4.755M
September 30, 2020 -0.978M
June 30, 2020 2.523M
Date Value
March 31, 2020 -0.361M
December 31, 2019 1.375M
September 30, 2019 0.843M
June 30, 2019 -0.098M
March 31, 2019 1.072M
December 31, 2018 0.809M
September 30, 2018 0.159M
June 30, 2018 1.204M
March 31, 2018 0.404M
December 31, 2017 -0.36M
September 30, 2017 0.914M
June 30, 2017 1.249M
March 31, 2017 0.984M
December 31, 2016 0.438M
September 30, 2016 -0.074M
June 30, 2016 -0.367M
March 31, 2016 -0.796M
December 31, 2015 0.288M
September 30, 2015 -0.638M
June 30, 2015 -0.353M
March 31, 2015 -0.723M
December 31, 2014 -0.445M
September 30, 2014 0.438M
June 30, 2014 -0.063M
March 31, 2014 0.28M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 509.00M
Abbott Laboratories 1.991B
AngioDynamics, Inc. -18.48M
Alphatec Holdings, Inc. -1.582M
AtriCure, Inc. 18.43M